Product
TOUR006
Aliases
TOUR006 - 50 MG
2 clinical trials
8 indications
Indication
Graves' DiseaseIndication
Chronic Kidney DiseaseIndication
Chronic Kidney InsufficiencyIndication
Kidney InsufficiencyIndication
ChronicIndication
C-reactive proteinIndication
CRPIndication
hs-CRPClinical trial
A Multicenter Phase 2b Randomized, Double-Masked, Placebo-Controlled Dose-Ranging Study of TOUR006 in Participants With Thyroid Eye DiseaseStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Quarterly and Monthly TOUR006 in Participants With Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive ProteinStatus: Recruiting, Estimated PCD: 2025-05-01